Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
L3Harris
LHX
|
+$230M |
| 2 |
Amazon
AMZN
|
+$158M |
| 3 |
Wells Fargo
WFC
|
+$135M |
| 4 |
Stanley Black & Decker
SWK
|
+$133M |
| 5 |
Honeywell
HON
|
+$128M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$266M |
| 2 |
KSU
Kansas City Southern
KSU
|
+$209M |
| 3 |
ExxonMobil
XOM
|
+$185M |
| 4 |
XEC
CIMAREX ENERGY CO
XEC
|
+$157M |
| 5 |
Salesforce
CRM
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.11% |
| 2 | Industrials | 11.28% |
| 3 | Financials | 10.43% |
| 4 | Consumer Discretionary | 9.72% |
| 5 | Healthcare | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Cirrus Logic
CRUS
$5.78B
| $12.5M | 0.04% |
135,766
+110,129
| +430% | +$9.15M |
|
|
NEWR
552
DELISTED
New Relic, Inc.
NEWR
| $12.4M | 0.04% |
113,127
+102,632
| +978% | +$9.9M |
|
553
Box
BOX
$4.56B
| $12.4M | 0.04% |
+473,839
| New | +$12.2M |
|
554
Cinemark Holdings
CNK
$4.24B
| $12.4M | 0.04% |
+767,038
| New | +$14.4M |
|
555
M/I Homes
MHO
$3.85B
| $12.4M | 0.04% |
+198,675
| New | +$11.9M |
|
|
MRSH
556
Marsh
MRSH
$91.6B
| $12.3M | 0.04% |
+70,838
| New | +$11.8M |
|
|
SUM
557
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $12.3M | 0.04% |
311,261
+97,612
| +46% | +$3.57M |
|
|
LUXA
558
DELISTED
Lux Health Tech Acquisition Corp. Class A Common Stock
LUXA
| $12.2M | 0.04% |
1,242,510
| – | – |
|
559
Copart
CPRT
$31.3B
| $12.2M | 0.04% |
320,892
-370,952
| -54% | -$13.8M |
|
560
GSK
GSK
$105B
| $12.1M | 0.04% |
219,734
-189,430
| -46% | -$9.85M |
|
|
XHR
561
Xenia Hotels & Resorts
XHR
$1.79B
| $12.1M | 0.04% |
666,551
+503,655
| +309% | +$8.89M |
|
562
PUT
State Street Consumer Staples Select Sector SPDR ETF
XLP
$15B
| $12.1M | 0.04% |
156,500
+6,500
| +4% | +$471K |
|
563
Kanzhun
BZ
$7.13B
| $12.1M | 0.04% |
345,603
+56,007
| +19% | +$1.97M |
|
564
PUT
TSMC
TSM
$2.17T
| $12M | 0.04% |
+100,000
| New | +$11.7M |
|
565
CALL
Iovance Biotherapeutics
IOVA
$3.76B
| $12M | 0.04% |
630,000
+25,000
| +4% | +$550K |
|
566
Imperial Oil
IMO
$66.8B
| $12M | 0.04% |
+333,293
| New | +$11.5M |
|
567
Victory Capital Holdings
VCTR
$7.11B
| $12M | 0.04% |
328,544
+275,307
| +517% | +$10M |
|
|
EXE
568
Expand Energy Corp
EXE
$22.2B
| $11.9M | 0.04% |
+184,643
| New | +$11.7M |
|
|
FSRX
569
DELISTED
FinServ Acquisition Corp. II Class A Common Stock
FSRX
| $11.9M | 0.04% |
1,225,000
| – | – |
|
|
PRSU
570
Pursuit Attractions and Hospitality Inc
PRSU
$1.33B
| $11.8M | 0.04% |
275,653
+37,872
| +16% | +$1.73M |
|
|
SCHW
571
CALL
Charles Schwab
SCHW
$194B
| $11.7M | 0.04% |
+139,500
| New | +$11.3M |
|
572
AstraZeneca
AZN
$257B
| $11.7M | 0.04% |
+100,599
| New | +$11.8M |
|
573
Alaska Air
ALK
$4.51B
| $11.7M | 0.04% |
224,619
-332,851
| -60% | -$18M |
|
574
CALL
Moderna
MRNA
$57.9B
| $11.7M | 0.04% |
+46,000
| New | +$13.4M |
|
575
Teleflex
TFX
$5.88B
| $11.7M | 0.04% |
+35,496
| New | +$12.1M |
|
Similar funds
Dmitry Balyasny's Q4 2021 Portfolio in Review
As of Q4 2021, Dmitry Balyasny held 2,811 positions worth $29.2B, up 22% from $24B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Dmitry Balyasny deployed $2.95B of net new capital in Q4 2021, opening 929 new positions and adding to 443 existing holdings. Its largest new stake was L3Harris: 1,037,704 shares worth $221M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 17% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $266M trimmed.
- Dmitry Balyasny's largest Q4 2021 buy was L3Harris: 1,037,704 shares worth $221M.
- Dmitry Balyasny added most to Honeywell in Q4 2021, an estimated $128M increase.
- Dmitry Balyasny's biggest Q4 2021 reduction was Goldman Sachs, cutting an estimated $266M.
- Dmitry Balyasny fully exited Kansas City Southern in Q4 2021, selling an estimated $209M.
- Dmitry Balyasny's ten largest holdings make up 13% of its $29.2B portfolio in Q4 2021.
- Dmitry Balyasny opened 929 new positions and closed 643 in Q4 2021.
- Dmitry Balyasny's portfolio value rose 22% quarter-over-quarter to $29.2B.
Based on Balyasny Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.